386 related articles for article (PubMed ID: 28466777)
1. The clinicopathological significance of forkhead box P1 and forkhead box O3a in pancreatic ductal adenocarcinomas.
Luo X; Yang Z; Liu X; Liu Z; Miao X; Li D; Zou Q; Yuan Y
Tumour Biol; 2017 May; 39(5):1010428317699129. PubMed ID: 28466777
[TBL] [Abstract][Full Text] [Related]
2. The clinical significance of FRAT1 and ABCG2 expression in pancreatic ductal adenocarcinoma.
Yuan Y; Yang Z; Miao X; Li D; Liu Z; Zou Q
Tumour Biol; 2015 Dec; 36(12):9961-8. PubMed ID: 26178481
[TBL] [Abstract][Full Text] [Related]
3. Glypican-3 and KRT19 are markers associating with metastasis and poor prognosis of pancreatic ductal adenocarcinoma.
Yao H; Yang Z; Liu Z; Miao X; Yang L; Li D; Zou Q; Yuan Y
Cancer Biomark; 2016; 17(4):397-404. PubMed ID: 27689616
[TBL] [Abstract][Full Text] [Related]
4. Comparison of ILK and ERP29 expressions in benign and malignant pancreatic lesions and their clinicopathological significances in pancreatic ductal adenocarcinomas.
Zhang K; Yao H; Yang Z; Li D; Yang L; Zou Q; Yuan Y; Miao X
Clin Transl Oncol; 2016 Apr; 18(4):352-9. PubMed ID: 26887611
[TBL] [Abstract][Full Text] [Related]
5. LDHB and FABP4 are Associated With Progression and Poor Prognosis of Pancreatic Ductal Adenocarcinomas.
Luo Y; Yang Z; Li D; Liu Z; Yang L; Zou Q; Yuan Y
Appl Immunohistochem Mol Morphol; 2017; 25(5):351-357. PubMed ID: 26657874
[TBL] [Abstract][Full Text] [Related]
6. BIRC7 and KLF4 expression in benign and malignant lesions of pancreas and their clinicopathological significance.
Yang Z; Li D; Liu Z; Miao X; Yang L; Zou Q; Yuan Y
Cancer Biomark; 2016; 17(4):437-444. PubMed ID: 27802195
[TBL] [Abstract][Full Text] [Related]
7. Expression of UGP2 and CFL1 expression levels in benign and malignant pancreatic lesions and their clinicopathological significance.
Wang L; Xiong L; Wu Z; Miao X; Liu Z; Li D; Zou Q; Yang Z
World J Surg Oncol; 2018 Jan; 16(1):11. PubMed ID: 29347944
[TBL] [Abstract][Full Text] [Related]
8. The Clinical and Pathological Significance of Nectin-2 and DDX3 Expression in Pancreatic Ductal Adenocarcinomas.
Liang S; Yang Z; Li D; Miao X; Yang L; Zou Q; Yuan Y
Dis Markers; 2015; 2015():379568. PubMed ID: 26294807
[TBL] [Abstract][Full Text] [Related]
9. Overexpression of B2M and loss of ALK7 expression are associated with invasion, metastasis, and poor-prognosis of the pancreatic ductal adenocarcinoma.
Liu C; Yang Z; Li D; Liu Z; Miao X; Yang L; Zou Q; Yuan Y
Cancer Biomark; 2015; 15(6):735-43. PubMed ID: 26406402
[TBL] [Abstract][Full Text] [Related]
10. High ROR2 expression in tumor cells and stroma is correlated with poor prognosis in pancreatic ductal adenocarcinoma.
Huang J; Fan X; Wang X; Lu Y; Zhu H; Wang W; Zhang S; Wang Z
Sci Rep; 2015 Aug; 5():12991. PubMed ID: 26259918
[TBL] [Abstract][Full Text] [Related]
11. AQP1 and AQP3 Expression are Associated With Severe Symptoms and Poor-prognosis of the Pancreatic Ductal Adenocarcinoma.
Zou W; Yang Z; Li D; Liu Z; Zou Q; Yuan Y
Appl Immunohistochem Mol Morphol; 2019 Jan; 27(1):40-47. PubMed ID: 30531392
[TBL] [Abstract][Full Text] [Related]
12. BTG1 low expression in pancreatic ductal adenocarcinoma is associated with a poorer prognosis.
Huang Y; Zheng J; Tan T; Song L; Huang S; Zhang Y; Lin L; Liu J; Zheng P; Chen X; Chen X; Ouyang X
Int J Biol Markers; 2018 May; 33(2):189-194. PubMed ID: 29076521
[TBL] [Abstract][Full Text] [Related]
13. Correlations of Foxo3 and Foxo4 expressions with clinicopathological features and prognosis of bladder cancer.
Wang Y; Kang XL; Zeng FC; Xu CJ; Zhou JQ; Luo DN
Pathol Res Pract; 2017 Jul; 213(7):766-772. PubMed ID: 28554751
[TBL] [Abstract][Full Text] [Related]
14. High expression of ErbB3 binding protein 1 (EBP1) predicts poor prognosis of pancreatic ductal adenocarcinoma (PDAC).
Gong C; Zhang Y; Chen Y; Zhang H; Liu X; Xue H; Ji L; Wang L; Yang L; Zhou G; Wan C
Tumour Biol; 2015 Dec; 36(12):9189-99. PubMed ID: 26088450
[TBL] [Abstract][Full Text] [Related]
15. Expression and clinical significance of placenta-specific 1 in pancreatic ductal adenocarcinoma.
Yin Y; Zhu X; Huang S; Zheng J; Zhang M; Kong W; Chen Q; Zhang Y; Chen X; Lin K; Ouyang X
Tumour Biol; 2017 Jun; 39(6):1010428317699131. PubMed ID: 28618924
[TBL] [Abstract][Full Text] [Related]
16. Linc00675 is a novel marker of short survival and recurrence in patients with pancreatic ductal adenocarcinoma.
Li DD; Fu ZQ; Lin Q; Zhou Y; Zhou QB; Li ZH; Tan LP; Chen RF; Liu YM
World J Gastroenterol; 2015 Aug; 21(31):9348-57. PubMed ID: 26309360
[TBL] [Abstract][Full Text] [Related]
17. Overexpression of FZD1 and CAIX are Associated with Invasion, Metastasis, and Poor-Prognosis of the Pancreatic Ductal Adenocarcinoma.
Yang L; Yang Z; Li D; Liu Z; Zou Q; Yuan Y; Xu H
Pathol Oncol Res; 2018 Oct; 24(4):899-906. PubMed ID: 28921449
[TBL] [Abstract][Full Text] [Related]
18. Pattern of lymph node involvement and prognosis in pancreatic adenocarcinoma: direct lymph node invasion has similar survival to node-negative disease.
Pai RK; Beck AH; Mitchem J; Linehan DC; Chang DT; Norton JA; Pai RK
Am J Surg Pathol; 2011 Feb; 35(2):228-34. PubMed ID: 21263243
[TBL] [Abstract][Full Text] [Related]
19. The prognostic significance of cancer-associated fibroblasts in pancreatic ductal adenocarcinoma.
Park H; Lee Y; Lee H; Kim JW; Hwang JH; Kim J; Yoon YS; Han HS; Kim H
Tumour Biol; 2017 Oct; 39(10):1010428317718403. PubMed ID: 29025374
[TBL] [Abstract][Full Text] [Related]
20. Jagged1 and DLL4 expressions in benign and malignant pancreatic lesions and their clinicopathological significance.
Huang SF; Yang ZL; Li DQ; Liu ZY; Wang CW; Miao XY; Zou Q; Yuan Y
Hepatobiliary Pancreat Dis Int; 2016 Dec; 15(6):640-646. PubMed ID: 27919854
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
